pharma · Hematologic Malignancies · Solid Tumor, Adult
Farmatek
Zafatek
Farmatek is a pharma organization headquartered in Istanbul, JP. Primary therapeutic focus areas include Hematologic Malignancies, Solid Tumor, Adult, Lymphoma, B-Cell, B-cell Mediated Autoimmune Diseases, COPD. NovaPhar
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP HQ
1994 Founded
14 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
- Founded
- 1994
- Employees
- 14
- Programs
- 26
- Drugs
- 14
- Patents
- 53
FT516
Phase 1 · small molecule · Acute Myelogenous Leukemia
FT516 for Acute Myelogenous Leukemia is a Phase 1 program (small_molecule) at Zafatek with 1 ClinicalTrials.gov record(s).
Internal code FT516-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zafatek
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Acute Myelogenous Leukemia
- Status
- terminated
- Trials
- 1